Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)

About this funding opportunity

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.

Topic areas: Life Sciences and Health.

Funding amount

This cooperative agreement provides Varies in funding.

Deadline

Applications are due Sep 24, 2026. Confirm the exact closing time on the official program page before applying.

Who can apply

This opportunity is open to the following applicant types:

• SME
• Public Authorities
• NGOs
• Other
• Large Company
• University

Eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Agency

Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) is administered by National Institutes of Health (NIH), listed via Grants.gov.